Sciclone Pharma (SCLN) Reports Q3 EPS of $0.24

November 9, 2016 5:04 PM EST
Get Alerts SCLN Hot Sheet
Trade SCLN Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Sciclone Pharma (NASDAQ: SCLN) reported Q3 EPS of $0.24, versus $0.26 reported last year. Revenue for the quarter came in at $40.5 million, versus $42.9 million reported last year.

For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment